Health & Biotech

Drug approvals, clinical trials, biotechnology, medical research, public-health developments and regulatory decisions.

  1. A panel voted 10-0 to endorse the Galleri test for detecting multiple cancers through a single blood sample, according to the regulator.

  2. The FDA approved Lyrfigtu for advanced cholangiocarcinoma on September 23, 2026, targeting FGFR2-altered cases in adults, according to reports.

  3. A study found 76% of public health leaders reported harassment post-pandemic. Female officials faced higher rates, according to researchers.

  4. A workshop on testosterone therapy for menopausal women occurred on September 17, 2026. Public input was invited, according to the regulator.

  5. UMass Boston seniors will teach public health topics in three high schools this fall, marking the first project of the Boston SPHERE coalition.

  6. A filing describes the FDA's approval of Moderna’s mFlusiva flu vaccine for adults 50 and older, according to reports. Distribution includes CVS.

  7. FDA approved Amneal's lanreotide injection on September 18, 2026. The product launched commercially the same day, according to reports.

  8. A health conference featured discussions on vaccine policy, addressing federal actions amid rising measles cases, according to reports.

  9. Five mumps cases have been confirmed among SDSU athletes. Screenings and MMR boosters are being provided to close contacts, according to officials.

  10. A system with 37,000 AI agents analyzed over 55,000 clinical trials for drug discovery, according to findings published in Science.

  11. The FDA seeks public input on a pilot program to expedite clinical trials, aiming to reduce timelines by six to twelve months, according to reports.

  12. During a Senate hearing, Senator Cassidy discussed two measles deaths in Pennsylvania. He addressed vaccine safety with surgeon general nominee Dr. Saphier.